SEK 3.06
(0.0%)
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2023 | - SEK | 0.0% |
2022 | - SEK | 0.0% |
2021 | - SEK | 0.0% |
2020 | - SEK | 0.0% |
2019 | - SEK | 0.0% |
2018 | - SEK | 0.0% |
Year | Long Term Debt | Long Term Debt Growth |
---|---|---|
2024 Q2 | - SEK | 0.0% |
2024 Q1 | - SEK | 0.0% |
2024 Q3 | - SEK | 0.0% |
2023 Q3 | - SEK | 0.0% |
2023 FY | - SEK | 0.0% |
2023 Q1 | - SEK | 0.0% |
2023 Q4 | - SEK | 0.0% |
2023 Q2 | - SEK | 0.0% |
2022 Q3 | - SEK | 0.0% |
2022 FY | - SEK | 0.0% |
2022 Q2 | - SEK | 0.0% |
2022 Q1 | - SEK | 0.0% |
2022 Q4 | - SEK | 0.0% |
2021 Q1 | - SEK | 0.0% |
2021 FY | - SEK | 0.0% |
2021 Q4 | - SEK | 0.0% |
2021 Q3 | - SEK | 0.0% |
2021 Q2 | - SEK | 0.0% |
2020 FY | - SEK | 0.0% |
2020 Q4 | - SEK | 0.0% |
2020 Q3 | - SEK | 0.0% |
2020 Q1 | - SEK | 0.0% |
2019 FY | - SEK | 0.0% |
2018 FY | - SEK | 0.0% |
Name | Long Term Debt | Long Term Debt Difference |
---|---|---|
Aino Health AB (publ) | 164 Thousand SEK | 100.0% |
Bonzun AB (publ) | 554 Thousand SEK | 100.0% |
Kontigo Care AB (publ) | 3.67 Million SEK | 100.0% |
RaySearch Laboratories AB (publ) | 431.97 Million SEK | 100.0% |
Surgical Science Sweden AB (publ) | 40.02 Million SEK | 100.0% |